● LIVE
NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40
Login☆ Watchlist
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommoditiesIPOs
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingStartupsEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth

BAJAJHCARE

BSE
Bajaj Healthcare Limited
Healthcare· Pharmaceuticals & Biotechnology· INE411U01027· Scrip: 539872
ENहिन्दीગુજરાતીमराठी
290.35
1.60 (+0.00%)
2026-06-10
BSE
290.35
1.60
+0.00%
27433940547153706-1608-0710-0311-2801-2303-2005-2506-10
233 trading days · 1Y period
TODAY (BSE)
Open295.00
High299.25
Low288.45
Prev Close291.95
Volume4,442
Value₹0.1Cr
L: 288.45H: 299.25
Info
Face Value₹5
Listed2021-11-25
ISININE411U01027
SeriesB
BSE Scrip539872

Key Metrics

1D
1W
1M
3M
6M
Growth (QoQ)
Revenue-7.74%
PAT+23.85%
EPS+8.63%
Profitability
Dividend
Growth+0.00%
TTM Revenue
₹522 Cr
TTM EBITDA
₹54 Cr
TTM PAT
₹-2 Cr
TTM EPS
₹-1.24
Rev/Share
₹155.1

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr40 Cr79 Cr119 Cr158 Cr23-0323-0623-0923-1224-0324-0624-0924-121.3-17.5-1.3-0.8-10.82.63.43.6
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-31123 Cr114 Cr21 Cr12 Cr12 Cr3.65
2024-09-30133 Cr123 Cr31 Cr12 Cr9 Cr3.36
2024-06-30132 Cr123 Cr28 Cr10 Cr7 Cr2.59
2024-03-31134 Cr131 Cr-25 Cr-35 Cr-30 Cr-10.84
2023-12-31109 Cr103 Cr21 Cr6 Cr-2 Cr-0.80
2023-09-30101 Cr97 Cr20 Cr5 Cr-3 Cr-1.25
2023-06-30130 Cr123 Cr22 Cr7 Cr-48 Cr-17.46
2023-03-31158 Cr154 Cr21 Cr5 Cr4 Cr1.30

Shareholding Pattern

CURRENT2026-03-31
58.3%PROMOTER
Promoter58.3%
FII2.0%
DII2.9%
Public41.7%
PROMOTER HOLDING TREND
59.2%24-0959.2%24-1259.2%25-0359.2%25-0959.2%25-1258.3%26-0358.3%26-03

Corporate Actions

Ex-DateTypePurpose
2025-09-19DividendDividend - Re 1 Per Share
2024-09-23DividendAnnual General Meeting/Dividend - Re 1 Per Share
2023-09-22DividendAnnual General Meeting/Dividend - Re 1 Per Share
2022-09-22DividendAnnual General Meeting/Dividend - Rs 1.50 Per Share

Earnings Transcripts

Price History

DateOpenHighLowCloseVolume
2026-06-10292.10297.00288.10291.1553,774
2026-06-03299.80301.80293.25298.7054,547
2026-05-27308.00314.90302.65307.052.17L
2026-05-26302.30308.65299.60305.251.03L
2026-05-25305.55310.40301.10302.5087,888
2026-05-22305.95308.00300.60305.5575,714
2026-05-21303.50307.50297.45304.451.99L
2026-05-20288.00303.00284.00298.701.44L
2026-05-19279.75293.40277.05288.554.00L
2026-05-18284.15285.30272.35274.951.59L
2026-05-15298.70298.70283.05284.152.39L
2026-05-14296.00300.05290.15293.6581,980
2026-05-13300.00301.45294.40295.301.25L
2026-05-12305.00309.35290.30292.802.29L
2026-05-11300.00318.95299.95304.508.20L
2026-05-08339.95340.50326.95336.554.16L
2026-05-07337.90348.00334.55339.702.29L
2026-05-06327.00345.70325.80334.854.30L
2026-05-05326.00330.00322.00324.8585,817
2026-05-04322.80332.30322.80327.851.08L
2026-04-30323.00328.00319.00321.7571,312
2026-04-29328.00330.00322.20324.0554,441
2026-04-28334.90334.90320.80324.501.37L
2026-04-27328.95335.50325.00331.801.08L
2026-04-24336.95336.95322.00323.801.40L
2026-04-23334.00339.80330.70332.851.23L
2026-04-22331.90334.00328.00332.751.00L
2026-04-21335.00336.45326.45328.551.58L
2026-04-20349.55353.80332.00333.801.93L
2026-04-17348.05353.95342.80349.551.59L

Frequently Asked Questions

About

Bajaj Healthcare Limited, incorporated in 1993, is a prominent Indian pharmaceutical company known for manufacturing a diverse range of Active Pharmaceutical Ingredients (APIs) and finished drug formulations. The company serves both domestic and international markets, catering to the pharmaceutical, nutraceutical, and food industries with a focus on quality and compliance. Notably, Bajaj Healthcare has established itself as a key player in the global API market, contributing significantly to the pharmaceutical supply chain.

BOARD OF DIRECTORS
Dhananjay Sabaji Hatle
Whole-time Director
DEPARTED
Gopalakrishnan Kesavan
Independent Director
Luke Fernandez
Independent Director
DEPARTED
Purnima Dhanraj Amin
Independent Director
Sandeep Shah
Independent Director
DEPARTED
Umeshkumar Laxmidas Bhavsar
Independent Director
Yaqoob Ali
Independent Director
DEPARTED